Adendra Therapeutics is a series a startup. 2 investors tracked. Status: possibledead.
Adendra Therapeutics is a startup based in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Adendra Therapeutics develops gene therapies targeting rare genetic disorders using advanced delivery technologies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.